<!DOCTYPE html>
<html lang="en">
<head>
<title>Shunts, Stents and Devices </title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
<link rel="stylesheet" type="text/css" href="../../../public/css/offline.css" />
<script src="../../../public/javascripts/jquery-1.10.2.min.js"></script>
</head>
<body class="dsg-wb">

<table width="80%" class="offline">
<tr>
  <td colspan="3" class="header"><h1><a href="/">JPAC</a> <span>Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee</span></h1></td>
</tr>
<tr class="tabs">
  <td colspan="3">
              <ul>
                  <li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components"><a href="../../../dsg/wb/guidelines.html"  class="active">Whole Blood and Components</a></li>
                  <li id="ddb09bf2-3dc0-4eb2-ba57-a5db69331dd1" class="geographical-disease-risk-index"><a href="../../../dsg/gdri/guidelines.html" >Geographical Disease Risk Index</a></li>
                </ul>
        </td>
</tr>
<tr>
  <td class="spacerow" colspan="3"></td>
</tr>
<tr>
  <td class="sidebar" width="25%">
    <div class="well">
          <ul class="openContentSectionWithSubs sidebarTopHeader"><li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components sectionHead first last"><a href="../../../dsg/wb.html">Whole Blood and Components</a>
<ul class="">
<li id="42be2de8-89aa-4908-8bc8-702f9e636a81" class="a-z-search active first"><a href="../../../dsg/wb/guidelines.html">A-Z Search</a>
</li><li id="1f7e1f13-8b29-4772-ae9d-2b5cc3d59491" class="updates"><a href="../../../dsg/wb/latest-updates.html">Updates</a>
</li><li id="f83d68fb-19de-4588-9a36-a8bba0aa6494" class="drug-index"><a href="../../../dsg/wb/drug-index.html">Drug Index</a>

</li><li id="769da873-1c35-4600-8be8-d2df902570a0" class="preliminaries"><a href="../../../dsg/wb/preliminaries.html">Preliminaries</a>
<ul class="">
<li id="258895c3-f3dd-45c6-932c-3fe4795870c2" class="introduction first"><a href="../../../dsg/wb/preliminaries/introduction.html">Introduction</a>
</li><li id="ef298454-8327-4f6c-9f4a-835e437df103" class="document-and-change-control"><a href="../../../dsg/wb/preliminaries/document-and-change-control.html">Document and Change Control</a>
</li><li id="093e6463-a089-49dd-9199-c8f92559f486" class="general-principles"><a href="../../../dsg/wb/preliminaries/general-principles.html">General Principles</a>
</li><li id="96f75c3a-2c62-445b-847c-353098eaec1e" class="medication"><a href="../../../dsg/wb/preliminaries/medication.html">Medication</a>
</li><li id="ed51942d-a7fd-42f7-8269-d23b879f99ca" class="inspection-of-the-donor"><a href="../../../dsg/wb/preliminaries/inspection-of-the-donor.html">Inspection of the Donor</a>
</li><li id="99af8b5e-491b-4d67-b69a-812d81af4d7d" class="use-of-alphabetical-listing last"><a href="../../../dsg/wb/preliminaries/use-of-alphabetical-listing.html">Use of Alphabetical Listing</a>
</li></ul>
</li><li id="753eb36f-2636-414c-84ee-1004e197502d" class="appendices"><a href="../../../dsg/wb/appendicies.html">Appendices</a>
<ul class="">
<li id="e147bd96-a025-4ffa-b530-b9abefc27043" class="appendix-1---estimated-blood-volume-for-female-donors-after-nadler--by-height-and-weight first"><a href="../../../dsg/wb/appendicies/appendix-1.html">Appendix 1 - Estimated Blood Volume for Female donors (after Nadler)  by height and weight</a>
</li><li id="2f1eca54-e34f-4ece-90a4-7dfe0f210c8d" class="appendix-2---table-of-immunisations-"><a href="../../../dsg/wb/appendicies/appendix-2-table-of-immunizations.html">Appendix 2 - Table of Immunisations </a>
</li><li id="a27f8ce9-b4f6-4a9b-baf0-6f655955a9aa" class="appendix-3---maximum-permitted-ecv-for-component-donors"><a href="../../../dsg/wb/appendicies/appendix-3-maximum-permitted-extra-corporeal-volume-for-component-donors.html">Appendix 3 - Maximum permitted ECV for component donors</a>
</li><li id="90c869cb-7256-4604-8699-d8a86f78aa26" class="appendix-4---management-of-post-donation-illness last"><a href="../../../dsg/wb/appendicies/appendix-4-management-of-post-donation-illness.html">Appendix 4 - Management of post donation illness</a>
</li></ul>
</li><li id="b62a2d12-6d94-4106-92a8-1de426a4b863" class="source-files last"><a href="../../../dsg/wb/source-files.html">Source Files</a>
</li></ul>
</li></ul>
    </div>
  </td>
  <td width="5%"></td>
  <td width="70%" class="content">
    <h2>Shunts, Stents and Devices </h2>    

<table class="data-table"><tbody><tr class="data-row"><td class="data-label">Includes</td><td class="data-value"><p><strong>Shunts</strong></p>


<ul>
	<li>For hydrocephalus e.g. ventriculo-peritoneal, -atrial, -pleural and lumboperitoneal shunts</li>
</ul>


<p><br />
<strong>Stents</strong></p>


<ul>
	<li>Vascular stents including coronary artery stents</li>
	<li>Urinary tract stents including ureteric stents</li>
	<li>Ophthalmic stents including nasolacrimal and Schlemm canal stents</li>
</ul>


<p><br />
<strong>Pacemakers</strong></p>


<ul>
	<li>Cardiac pacemakers</li>
	<li>Gastric pacemakers</li>
</ul>


<p><br />
<strong>Implanted neuromodulator and nerve stimulator devices, used for:</strong></p>


<ul>
	<li>Neuropathic pain &#8211; includes spinal cord and peripheral nerve stimulators</li>
	<li>Bladder dysfunction - includes sacral nerve stimulators</li>
	<li>​Gastroparesis &#8211; sometimes referred to as gastric pacemakers</li>
</ul>


<p><br />
<strong>Glucose monitoring devices</strong></p>


<ul>
	<li>Real time continuous glucose monitors (rtCGM)</li>
	<li>​Intermittently scanned glucose monitors (isCGM) &#8211; flash glucose monitors</li>
</ul></td></tr><tr class="data-row"><td class="data-label">Obligatory</td><td class="data-value"><p><b>Must not donate.</b></p></td></tr><tr class="data-row"><td class="data-label">Discretionary</td><td class="data-value"><p>a). If the indication for an implanted neuromodulator device does not preclude donation and the site of implantation is fully healed, accept.</p>


<p><br />
b). If an ophthalmic stent has been successfully inserted with good effect, the area has fully healed and there is no infection, accept.</p>


<p><br />
c) If the reason for using a glucose monitoring device does not preclude donation and there is no inflammation or infection at, or around, the site of the skin sensor, accept.</p></td></tr><tr class="data-row"><td class="data-label">See if Relevant</td><td class="data-value"><p><a href="../../../dsg/wb/guidelines/ar001-arrhythmias.html">Arrhythmia</a><br />
<a href="../../../dsg/wb/guidelines/ca007-cardiovascular-disease.html">Cardiovascular Disease</a><br />
<a href="../../../dsg/wb/guidelines/di003-diabetes-mellitus.html">Diabetes Mellitus</a><br />
<a href="../../../dsg/wb/guidelines/ey002-eye-disease.html">Eye disease</a><br />
<a href="../../../dsg/wb/guidelines/ga009-gastrointestinal-disease.html">Gastrointestinal Disease</a><br />
<a href="../../../dsg/wb/guidelines/ki001-kidney-disease.html">Kidney and Bladder Disease</a><br />
<a href="../../../dsg/wb/guidelines/ne007-neurosurgery.html">Neurosurgery</a><br />
<a href="../../../dsg/wb/guidelines/sp002-spina-bifida.html">Spina Bifida</a></p></td></tr><tr class="data-row"><td class="data-label">Additional Information</td><td class="data-value"><p>Some shunts and stents can be a source of bacterial infection due to their location in the body and infection can be present without symptoms.</p>


<p><br />
Bacteria can be a serious threat to anybody receiving blood or blood components. This is because bacteria can multiply to dangerous levels after collection.</p>


<p><br />
Implanted neuromodulator devices and some stents are not a covert infection risk once the implantation site is fully healed and there are no signs of infection or inflammation.</p>


<p><br />
Care should be taken to ensure that the underlying condition that requires the use of a neuromodulator device does not preclude donation, and that the donor is well at the time of donation.</p>



<p><br />
Care should be taken to ensure that the reason that a glucose monitoring device is being used does not preclude donation or make it inadvisable at that time. These devices are not a covert infection risk as any local infection or inflammation should be apparent. The <a href="../../../dsg/wb/guidelines/di003-diabetes-mellitus.html">Diabetes Mellitus</a> entry should always be referred to for diabetic donors using these devices.</p></td></tr><tr class="data-row"><td class="data-label">Reason for change</td><td class="data-value"><p>Addition of advice for donors with glucose monitoring devices.<br />
Addition of Diabetes Mellitus to See if Relevant section.</p></td></tr><tr class="data-row"><td class="data-label">Donor Information</td><td class="data-value"><p>If you wish to obtain more information regarding a personal medical issue, please contact your <a href="../../../dsg/wb/guidelines/nn099-national-help-lines.html">National Help Line</a>.<br />
<br />
Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.</p></td></tr></tbody></table>
<div class="pull-right attachments"><div class="cms images">
  
</div></div>

  
<dl class="update-information"><dt class="data-label"><h4>Update Information</h4></dt><dd class="data-value"><p>This entry was last updated in:<br />
WB-DSG&nbsp;Edition 203&nbsp;Release 72</p></dd></dl>  </td>
</tr>
</table>
</body>
</html>